Estadístiques de Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-Cell lymphoma: final results of the R2-GDP-GOTEL trial and immune biomarker subanalysis
Visites totals
| views | |
|---|---|
| Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-Cell lymphoma: final results of the R2-GDP-GOTEL trial and immune biomarker subanalysis | 68 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| palazon-ccr-lena.pdf(legacy) | 38 |
| palazon-ccr-lena.pdf | 32 |
Vistes principals per país
| views | |
|---|---|
| United States | 39 |
| Belgium | 8 |
| Japan | 8 |
| Spain | 5 |
| United Kingdom | 3 |
| India | 2 |
| Germany | 1 |
| Iran | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Tokyo | 8 |
| Ann Arbor | 6 |
| Mountain View | 5 |
| San Ramon | 5 |
| Boardman | 4 |
| Menlo Park | 4 |
| Barcelona | 2 |
| Fairfield | 2 |
| Leicester | 2 |
| Redwood City | 2 |
| Almería | 1 |
| Arganda | 1 |
| Cardiff | 1 |
| Dearborn | 1 |
| Jaén | 1 |
| Las Vegas | 1 |
| Neuenhagen | 1 |
| Oakland | 1 |
| Portland | 1 |
| Salt Lake City | 1 |
| San Diego | 1 |
| Shah Alam | 1 |